NCT03780933View on ClinicalTrials.gov

the Effect of High Dose Ascorbic Acid on Critically Ill Patients With ARDS

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 5, 2017

Primary Completion Date

June 20, 2019

Study Completion Date

June 20, 2019

Conditions
Acute Respiratory Distress
Interventions
DIETARY_SUPPLEMENT

vitamin c

vitamin c IV 10 G

Trial Locations (1)

Unknown

Embaba Chest Hospitals, Cairo

All Listed Sponsors
lead

Misr International University

OTHER

NCT03780933 - the Effect of High Dose Ascorbic Acid on Critically Ill Patients With ARDS | Biotech Hunter | Biotech Hunter